Efficacy and safety of programmed death receptor-1 (PD-1) blockade in metastatic uveal melanoma (UM)
Tsai, Katy K., Shoushtari, Alexander Noor, Munhoz, Rodrigo Ramella, Eroglu, Zeynep, Piulats, Josep M., Ott, Patrick Alexander, Johnson, Douglas Buckner, Hwang, Jimmy, Daud, Adil, Sosman, Jeffrey Alan, Carvajal, Richard D., Chmielowski, Bartosz, Postow, Michael Andrew, Weber, Jeffrey S., Sullivan, Ryan J., Algazi, Alain Patrick
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Abstract 4086: Histone deacetylase 6 (HDAC6) as a new target modulating the proliferation and immune-related pathways in melanoma
Perez-Villarroel, Patricio, Lienlaf, Maritza, Lee, Calvin, Cheng, Fengdong, Woods, David, Barrios, Kelly, Woan, Karrune, Canales, Jorge, Knox, Tessa, Marante, Danay, Wang, Hongwei, Horna, Pedro, Smalley, Keiran, Celis, Esteban, Seto, Ed, Weber, Jeffrey S., Sotomayor, Eduardo M., Villagra, Alejandro
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Abstract 4089: Histone deacetylase 6 (HDAC6) as a regulator of PD-L1 expression through STAT3 modulation in melanoma
Lienlaf, Maritza, Perez-Villarroel, Patricio, Lee, Calvin, Cheng, Fengdong, Canales, Jorge, Knox, Tessa, Marante, Danay, Sarnaik, Amod, Horna, Pedro, Seto, Ed, Smalley, Keiran, Weber, Jeffrey S., Sotomayor, Eduardo M., Villagra, Alejandro
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Ipilimumab (Ipi) retreatment at 10 mg/kg in patients with metastatic melanoma previously treated in phase II trials
Neyns, Bart, Weber, Jeffrey S., Lebbé, Celeste, Maio, Michele, Harmankaya, Kaan, Hamid, Omid, O'Day, Steven, Chin, Kevin M., McDowell, Diane Opatt, Cykowski, Lori, McHenry, Brent, Wolchok, Jedd D.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Safety and efficacy of adjuvant anti-PD1 therapy (nivolumab) in combination with vaccine in resected high-risk metastatic melanoma
Gibney, Geoffrey Thomas, Weber, Jeffrey S., Kudchadkar, Ragini Reiney, De Conti, Ronald C., Tetteh, Leticia, Eysmans, Cabell, Yu, Bin, Martinez, Alberto J, Younos, Ibrahim
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Long-term survival in patients with metastatic melanoma who received ipilimumab in four phase II trials
Lebbé, Celeste, Weber, Jeffrey S., Maio, Michele, Neyns, Bart, Harmankaya, Kaan, Hamid, Omid, O'Day, Steven, Chin, Kevin M., McDowell, Diane Opatt, Cykowski, Lori, McHenry, Brent, Wolchok, Jedd D.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Ipilimumab retreatment following induction therapy: The expanded access program (EAP) experience
Margolin, Kim Allyson, Hamid, Omid, Weber, Jeffrey S., Pavlick, Anna C., Hodi, F. Stephen, Amin, Asim, Bennett, Kelly, Michener, Tracy, Minor, David R.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Costimulatory effect of agonistic 4-1BB antibody on proliferation and effector phenotype of tumor-infiltrating lymphocytes in melanoma
Sarnaik, Amod, Bilotto, Anthony, Jure-Kunkel, Maria, Hall, MacLean S, Wang, Wenshi, Younos, Ibrahim, Pilon-Thomas, Shari, Weber, Jeffrey S.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Updated survival, toxicity, and biomarkers of nivolumab with/without peptide vaccine in patients naive to, or progressed on, ipilimumab (IPI)
Weber, Jeffrey S., Kudchadkar, Ragini Reiney, Gibney, Geoffrey Thomas, Yu, Bin, Cheng, PingYan, Martinez, Alberto J, Kroeger, Jodi, Gallenstein, Donna, Richards, Allison, Welsh, Eric, Zhao, Xiuhua, Qu, Xiaotao, Chen, Ann
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Preliminary results from a phase 1/2 study of INCB024360 combined with ipilimumab (ipi) in patients (pts) with melanoma
Gibney, Geoffrey Thomas, Hamid, Omid, Gangadhar, Tara C., Lutzky, Jose, Olszanski, Anthony J., Gajewski, Thomas, Chmielowski, Bartosz, Boasberg, Peter D., Zhao, Yufan, Newton, Robert Charles, Scherle, Peggy A, Bowman, Jill, Maleski, Janet, Leopold, Lance, Weber, Jeffrey S.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A phase Ib/II study of BRAF inhibitor (BRAFi) encorafenib (ENCO) plus MEK inhibitor (MEKi) binimetinib (BINI) in cutaneous melanoma patients naive to BRAFi treatment
Sullivan, Ryan J., Weber, Jeffrey S., Patel, Sapna Pradyuman, Dummer, Reinhard, Miller, Wilson H., Cosgrove, David, Carlino, Matteo S., Tan, Daniel Shao-Weng, Lebbe, Celeste, Cipani, Tiziana, Élez, Elena, Maacke, Heiko, Nikolopoulos, Panagiotis, Aout, Mounir, De Parseval, Laure A., Ascierto, Paolo Antonio
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Association of immune-related thyroid disorders with pembrolizumab (pembro, MK-3475) in patients (pts) with advanced melanoma treated in KEYNOTE-001
Robert, Caroline, Joshua, Anthony M, Kefford, Richard, Joseph, Richard Wayne, Wolchok, Jedd D., Hodi, F. Stephen, Hamid, Omid, Weber, Jeffrey S., Gangadhar, Tara C., Dronca, Roxana Stefania, Patnaik, Amita, Zarour, Hassane M., Hwu, Wen-Jen, Hersey, Peter, Daud, Adil, Giannotti, Maxine, Li, Xiaoyun Nicole, Ebbinghaus, Scot, Kang, Soonmo Peter, Ribas, Antoni
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature
Ribas, Antoni, Robert, Caroline, Hodi, F. Stephen, Wolchok, Jedd D., Joshua, Anthony M, Hwu, Wen-Jen, Weber, Jeffrey S., Zarour, Hassane M., Kefford, Richard, Loboda, Andrey, Albright, Andrew, Kang, Soonmo Peter, Ebbinghaus, Scot, Yearley, Jennifer, Murphy, Erin, Nebozhyn, Michael, Lunceford, Jared K., McClanahan, Terri, Ayers, Mark, Daud, Adil
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Atypical patterns of response in patients (pts) with metastatic melanoma treated with pembrolizumab (MK-3475) in KEYNOTE-001
Wolchok, Jedd D., Hamid, Omid, Ribas, Antoni, Robert, Caroline, Kefford, Richard, Hwu, Wen-Jen, Weber, Jeffrey S., Joshua, Anthony M, Gangadhar, Tara C., Dronca, Roxana Stefania, Daud, Adil, Patnaik, Amita, Joseph, Richard Wayne, Zarour, Hassane M., Li, Xiaoyun Nicole, Xue, Dahai, Ebbinghaus, Scot, Kang, Soonmo Peter, Perrone, Andrea Marie, Hodi, F. Stephen
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001
Daud, Adil, Ribas, Antoni, Robert, Caroline, Hodi, F. Stephen, Wolchok, Jedd D., Joshua, Anthony M, Hwu, Wen-Jen, Weber, Jeffrey S., Gangadhar, Tara C., Joseph, Richard Wayne, Dronca, Roxana Stefania, Patnaik, Amita, Zarour, Hassane M., Kefford, Richard, Lindia, Jill Ann, Li, Xiaoyun Nicole, Ebbinghaus, Scot, Kang, Soonmo Peter, Hamid, Omid
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Updated overall survival (OS) results for BRF113220, a phase I–II study of dabrafenib alone versus combined dabrafenib and trametinib in patients with BRAF V600 metastatic melanoma (MM)
Daud, Adil, Weber, Jeffrey S., Sosman, Jeffrey Alan, Kim, Kevin, Gonzalez, Rene, Hamid, Omid, Infante, Jeffrey R., Cebon, Jonathan S., Schuchter, Lynn Mara, Long, Georgina V., Algazi, Alain Patrick, Kudchadkar, Ragini Reiney, Puzanov, Igor, Lawrence, Donald P., Kefford, Richard, Kline, Amy S., Del Buono, Heather Lynn, Sun, Peng, McDowell, Diane Opatt, Flaherty, Keith
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Histone Deacetylase 11 (HDAC11) Regulates Cytotoxic T-Cell Function and Memory Phenotype
Woods, David M, Woan, Karrune V., Sahakian, Eva, Powers, John, Cheng, Fengdong, Wang, Hongwei, Rock-Klotz, Jennifer, Weber, Jeffrey S., Villagra, Alejandro, Pinilla-Ibarz, Javier, Sotomayor, Eduardo M.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Abstract CT104: Antitumor activity of the anti-PD-1 monoclonal antibody MK-3475 in melanoma(MEL): Correlation of tumor PD-L1 expression with outcome
Daud, Adil I., Hamid, Omid, Ribas, Antoni, Hodi, F. Stephen, Hwu, Wen-Jen, Kefford, Richard, Wolchok, Jedd, Hersey, Peter, Weber, Jeffrey S., Joseph, Richard, Gangadhar, Tara C., Dronca, Roxana S., Patnaik, Amita, Zarour, Hassane, Joshua, Anthony M., Gergich, Kevin, Wu, Dianna, Lunceford, Jared K., Emancipator, Kenneth, Dolled-Filhart, Marisa, Li, Nicole, Ebbinghaus, Scot, Kang, S. Peter, Robert, Caroline
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL)
Ribas, Antoni, Hodi, F. Stephen, Kefford, Richard, Hamid, Omid, Daud, Adil, Wolchok, Jedd D., Hwu, Wen-Jen, Gangadhar, Tara C., Patnaik, Amita, Joshua, Anthony M., Hersey, Peter, Weber, Jeffrey S., Dronca, Roxana Stefania, Zarour, Hassane M., Gergich, Kevin, Li, Xiaoyun (Nicole), Iannone, Robert, Kang, Soonmo Peter, Ebbinghaus, Scot, Robert, Caroline
Published in Journal of clinical oncology (20.06.2014)
Published in Journal of clinical oncology (20.06.2014)
Get full text
Journal Article